HK1151288A1 - Acylthiourea compound or salt thereof, and use of the compound or the salt - Google Patents

Acylthiourea compound or salt thereof, and use of the compound or the salt

Info

Publication number
HK1151288A1
HK1151288A1 HK11105356.4A HK11105356A HK1151288A1 HK 1151288 A1 HK1151288 A1 HK 1151288A1 HK 11105356 A HK11105356 A HK 11105356A HK 1151288 A1 HK1151288 A1 HK 1151288A1
Authority
HK
Hong Kong
Prior art keywords
optionally substituted
group
salt
compound
alkyl group
Prior art date
Application number
HK11105356.4A
Other languages
English (en)
Inventor
Yoshimitsu Suda
Kosuke Egami
Hidenori Fujita
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1151288A1 publication Critical patent/HK1151288A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
HK11105356.4A 2008-04-10 2011-05-30 Acylthiourea compound or salt thereof, and use of the compound or the salt HK1151288A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008102832 2008-04-10
PCT/JP2009/001655 WO2009125597A1 (ja) 2008-04-10 2009-04-09 アシルチオウレア化合物又はその塩、及びその用途

Publications (1)

Publication Number Publication Date
HK1151288A1 true HK1151288A1 (en) 2012-01-27

Family

ID=41161733

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11105356.4A HK1151288A1 (en) 2008-04-10 2011-05-30 Acylthiourea compound or salt thereof, and use of the compound or the salt

Country Status (20)

Country Link
US (1) US8304427B2 (de)
EP (1) EP2287155B1 (de)
JP (1) JP4667537B2 (de)
KR (1) KR101414931B1 (de)
CN (1) CN101998951B (de)
AU (1) AU2009234978B2 (de)
BR (1) BRPI0911679B8 (de)
CA (1) CA2720552C (de)
CY (1) CY1114166T1 (de)
DK (1) DK2287155T3 (de)
ES (1) ES2423851T3 (de)
HK (1) HK1151288A1 (de)
HR (1) HRP20130984T1 (de)
MX (1) MX2010011097A (de)
PL (1) PL2287155T3 (de)
PT (1) PT2287155E (de)
RU (1) RU2503664C2 (de)
SI (1) SI2287155T1 (de)
TW (1) TWI438193B (de)
WO (1) WO2009125597A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314253B2 (en) 2008-07-01 2016-04-19 Amendia, Inc. Tissue modification devices and methods
AU2009303602B2 (en) 2008-10-14 2012-06-14 Sunshine Lake Pharma Co., Ltd. Compounds and methods of use
WO2010111063A1 (en) 2009-03-21 2010-09-30 Ning Xi Amino ester derivatives, salts thereof and methods of use
CN103003262A (zh) 2010-07-16 2013-03-27 协和发酵麒麟株式会社 含氮芳香族杂环衍生物
EP2684468A4 (de) * 2011-03-07 2014-08-27 Ajinomoto Kk Salzgeschmacksverstärker
TWI594986B (zh) * 2011-12-28 2017-08-11 Taiho Pharmaceutical Co Ltd Antineoplastic agent effect enhancer
CN104220058A (zh) 2012-01-27 2014-12-17 国立大学法人富山大学 丝氨酸消旋酶抑制剂
US9149471B2 (en) * 2013-09-30 2015-10-06 National University Corporation Tokyo University Of Agriculture And Technology Therapeutic agent for osteoporosis
JP6617155B6 (ja) * 2015-04-07 2020-01-22 グアンドン・レイノーヴェント・バイオテック・カンパニー・リミテッド チロシンキナーゼ阻害剤およびそれを含む医薬組成物
US10143688B2 (en) 2015-04-30 2018-12-04 Taiho Pharmaceutical Co., Ltd. Mesylic acid salt of acylthiourea compound, crystal of the same, and process for producing these
CA2990791A1 (en) * 2015-06-25 2016-12-29 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for fibrosis
CN105601566A (zh) * 2016-02-02 2016-05-25 张敏 一种护理烧伤后感染的药物组合物
WO2018028591A1 (zh) 2016-08-09 2018-02-15 殷建明 一种喹啉衍生物及其用途
MA47516A (fr) 2017-02-15 2021-03-31 Taiho Pharmaceutical Co Ltd Composition pharmaceutique
MA50251A (fr) * 2017-09-08 2021-06-02 Taiho Pharmaceutical Co Ltd Agent antitumoral et potentialisateur d'effet antitumoral
AU2019342447A1 (en) 2018-09-18 2021-04-08 Taiho Pharmaceutical Co., Ltd. Combination therapy of acylthiourea compound and abiraterone
TW202140426A (zh) 2020-02-14 2021-11-01 日商大鵬藥品工業股份有限公司 醯基硫脲化合物的製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
EP1243582A4 (de) 1999-12-24 2003-06-04 Kirin Brewery Chinolin- und chinazolinderivate sowie medikamente, die diese enthalten
EP1415987B1 (de) * 2000-10-20 2007-02-28 Eisai R&D Management Co., Ltd. Stickstoff-enthaltende aromatische ringverbindungen zur behandlung von tumorerkrankungen
JP4342935B2 (ja) * 2001-06-22 2009-10-14 協和発酵キリン株式会社 肝細胞増殖因子受容体自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
US6858637B2 (en) 2002-03-28 2005-02-22 Neurogen Corporation Substituted biaryl amides as C5a receptor modulators
JP4638436B2 (ja) 2003-09-26 2011-02-23 エグゼリクシス, インコーポレイテッド c−Metモジュレーターおよびその使用
EP1724268A4 (de) 2004-02-20 2010-04-21 Kirin Pharma Kk Verbindungen mit tgf-beta-hemmender wirkung und pharmazeutische zusammensetzung, die diese enthält
BRPI0507201A (pt) 2004-02-27 2008-06-10 Eisai R & D Man Company Ltd derivado de piridina e derivado de pirimidina (1)
WO2005121125A1 (en) * 2004-06-09 2005-12-22 Pfizer Inc. Ether-linked heteroaryl compounds
AU2006229343A1 (en) * 2005-03-28 2006-10-05 Kirin Pharma Kabushiki Kaisha Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
AU2006231646A1 (en) * 2005-04-06 2006-10-12 Exelixis, Inc. C-Met modulators and methods of use

Also Published As

Publication number Publication date
JP4667537B2 (ja) 2011-04-13
SI2287155T1 (sl) 2013-10-30
EP2287155B1 (de) 2013-07-17
CA2720552A1 (en) 2009-10-15
CY1114166T1 (el) 2016-08-31
RU2503664C2 (ru) 2014-01-10
US20110034439A1 (en) 2011-02-10
RU2010145526A (ru) 2012-05-20
PT2287155E (pt) 2013-07-26
BRPI0911679A2 (pt) 2015-10-13
BRPI0911679B8 (pt) 2021-05-25
PL2287155T3 (pl) 2013-12-31
AU2009234978A1 (en) 2009-10-15
DK2287155T3 (da) 2013-07-29
KR101414931B1 (ko) 2014-07-04
TW201000451A (en) 2010-01-01
HRP20130984T1 (hr) 2013-11-22
US8304427B2 (en) 2012-11-06
WO2009125597A1 (ja) 2009-10-15
BRPI0911679B1 (pt) 2020-09-29
TWI438193B (zh) 2014-05-21
CN101998951A (zh) 2011-03-30
JPWO2009125597A1 (ja) 2011-08-04
CA2720552C (en) 2016-06-14
MX2010011097A (es) 2010-11-01
AU2009234978B2 (en) 2014-03-06
KR20100132023A (ko) 2010-12-16
ES2423851T3 (es) 2013-09-24
EP2287155A4 (de) 2012-05-09
CN101998951B (zh) 2013-07-17
EP2287155A1 (de) 2011-02-23

Similar Documents

Publication Publication Date Title
HK1151288A1 (en) Acylthiourea compound or salt thereof, and use of the compound or the salt
CY1121051T1 (el) Περιεχουσα αζωτο ετεροκυκλικη ενωση και γεωργικο/κηπουρικο σποριοκτονο
IN2014DN10806A (de)
GEP201706728B (en) Noxious organism control agent
WO2012033858A3 (en) Benzoxaborole derivatives for treating bacterial infections
PH12014502117A1 (en) Tetrazolinone compounds and its use as pesticides
WO2013076316A3 (en) Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)hetarylcarboxamide compounds and their use as herbicides
MY169179A (en) Novel piperidine compound or salt thereof
EP2594555A4 (de) Heterozyklische verbindung und p27-kip-1-abbauhemmer
MX2016006685A (es) Compuestos heterociclicos de n-acilimino.
WO2013072528A3 (en) Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)pyridin-3-yl-carboxamide compounds and their use as herbicides
EP2589596A4 (de) Aromatisches aminderivat und organisches elektrolumineszenzelement damit
ECSP10010425A (es) Pirrolopirimidincarboxamidas
EP2602254A4 (de) Heterocyclische verbindung
IL229594A0 (en) Materials and preparations for the treatment of tumors
MY185421A (en) Heterocyclic amide compound and herbicide
MX2015004263A (es) Compuestos imida, metodo para fabricarlo y su uso como insecticida.
TN2012000034A1 (en) Methylpyrrolopyrimidinecarboxamides
WO2009130469A8 (en) Dna-pk inhibitors
WO2012126797A3 (de) Verwendung oligomerer carbodiimide als stabilisatoren
UA80686U (en) 5-(4-nitro-, (4-methoxy), (3,4,5-trimethoxy)phenyl)-4-amino(h)-3-thio-1,2,4-triazoles exhibiting antioxidant activity
WO2010032035A3 (en) Composition and method for removing hair from the skin
MX2007010218A (es) Compuestos de acido piridil acetico.
TH76129A (th) สารประกอบเคมี
TH126084B (th) อนุพันธ์ 5-ฟลูออโร-2-ออกโซพิริมิดีน-1(2h)-คาร์บอกซิเลท